References
- Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89:S116–28.
- Rune SJ. History of Helicobacter infection. Scand J Gastroenterol 1996;31 Suppl 214:2–4.
- Stolte M, Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996;31 Suppl 214:13–6.
- Hunt RH, Mohamed AH. The current role of H. pylori eradication in clinical practice. Scand J Gastroenterol 1995;30 Suppl 208:47–52.
- Figura N, Crabtree IE. H. pylori vacuolating toxin. In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori: basic mechanism to clinical cure. Dordrecht: Kulwer Academic Publisher; 1994. p. 222–31.
- Lichtenberger LA, Dial EJ, Romero JJ, Lechago J, Jarboe LA, Wolfe MM. Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology 1995;108:320–9.
- Slomiany BL, Piotrowski J, Slomiany A. Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide. Biochem Mol Biol Int 1997;42:155–61.
- Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Biochem Mol Biol Int 1995;36:491–8.
- Piotrowski J, Slomiany A, Slomiany BL. H. pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate. Biochem Mol Biol Int 1997;42: 545–51.
- Tomkins LS, Falkow S. The new path to prevent ulcers. Science 1995;267:1621–2.
- Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419–25.
- Eaton KA, Catrenick CE, Malkin KM, Krakowka S. Virulence of coccoid and bacillary forms of H. pylori in gnotobiotic piglets. J Infect Dis 1995;171:459–62.
- Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by H. pylori in gnotobiotic piglets. Infect Immun 1991;59:2470–5.
- Slomiany BL, Murty VLN, Piotrowski J, Slomiany A. Gastro protective agents in mucosal defense against H. pylori. Gen Pharmacol 1994;25:833–41.
- Slomiany A, Piotrowski J, Slomiany BL. Sucralfate inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide. Scand J Gastroenterol 1995;30 Suppl 210:77–83.
- Slomiany BL, Piotrowski J, Slomiany A. Anti-H. pylori activities of ebrotidine. Arzneimittelforsch Drug Res 1997;47: 475–82.
- Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide induces gastric epithelial cell apoptosis. Biochem Mol Biol Int 1996;40:597–602.
- Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A, Slomiany BL. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1997;32:203–11.
- Moss SF, Calam J, Agarawal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498–501.
- Nagata S. Apoptosis by death factor. Cell 1997;88:355–65.
- Mijatovic T, Kruys V, Caput D, Defrance P, Huez G. Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997;272: 1494–8.
- Orchansky PL, Ayres SD, Hilton DJ, Schrader JW. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J Biol Chem 1997;272:22940–7.
- Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209–22.
- Rauws EAJ, Langenberg W, Houthoff HJ, Zanen MC, Tytgat GNJ. Campylobacter pylori-associated chronic active antral gastritis. A prospective study of its prevalence and the effect of antibacterial and antiulcer treatment. Gastroenterology 1988; 94:33–40.
- Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55kDa receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307–16.
- Slomiany BL, Piotrowski J, Slomiany A. Induction of tumor necrosis factor-α and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine. Scand J Gastroenterol 1997;32: 638–42.
- Slomiany BL, Piotrowski J, Slomiany A. Chronic alcohol ingestion enhances tumor necrosis factor-α expression and salivary gland apoptosis. Alcohol Clin Exp Res 1997;21:1530–3.
- Slomiany BL, Piotrowski J, Rajiah G, Slomiany A. Inhibition of gastric mucosal laminin receptor by H. pylori lipopolysaccharide: effect of nitecapone. Gen Pharmacol 1991;22: 1063–9.
- Crabtree JE, Shallcross TM, Heatly RV, Wyatt JL. Mucosal tumor necrosis factor alpha and interleukin 6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473–7.
- Crabtree JE, Peichl P, Wyatt JL, Stachl U, Lindley IJ. Gastric interleukin 8 and IgA IL-8 antibodies in Helicobacter pylori infection. Scand J Gastroenterol 1993;37: 65–70.
- Moss SF, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated gastritis. Gut 1994;35:1567–70.
- Jin F, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997;88:417–26.
- Wallach D. Cell death induction by TNF: a matter of self control. TIBS 1997;22:107–9.
- Villa P, Kaufmann SH, Earnshaw WC. Caspases and caspase inhibitors. TIBS 1997;22:388–93.
- Beales I, Blaser MJ, Srinivasan S, Calam J, Perez-Perez GI, Yamada T, et al. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997;113:465–71.
- Velasco M, Diaz-Guerra MJM, Martin-Sanz P, Alvarez A, Bosca L. Rapid up-regulation of IκBβ and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J Biol Chem 1997;272:23025–30.
- Terano A, Shimada T, Hiraishi H. Sucralfate and Helicobacter pylori. J Gastroenterol 1996;31 Suppl IX:63–5.
- Winter TA, Louw JA, Marks IN, Jaskewicz K, Lucke W, Callanan M. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer. Scand J Gastroenterol 1995;30 Suppl 210:85–8.
- Banerjee S, El-Omar E, Mowat A, Ardill JES, Park RHR, Watson W, et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996;110:717–24.
- Hui WM, Lam SK, Ho J, Ng I, Lau WY, Branicki FJ, et al. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med 1988;86 Suppl 6A:60–5.